CEL-SCI Corporation (NYSE MKT:CVM) announced today that it has priced its public offering of common stock and warrants. CEL-SCI announced that it has agreed to sell 34,024,000 shares of common stock and warrants …
WFMJ2mon
CEL-SCI Corporation (NYSE MKT: CVM), a late-stage oncology company, today announced that it has closed …
In trials evaluating Axi-Cel in B-cell cancers, including diffuse large B-cell ... this could be a high-risk, high-reward stock that makes sense for long-term growth investors to buy. 10 stocks we like better than Kite Pharma …
Dow Jones Industrial Average
Dec 2 Cel-Sci Corp : * Cel-Sci announces pricing of $4.25 million public offering of common stock and warrants * Has agreed to sell 34 million shares of common stock and warrants to purchase common stock at a price of …
Reuters
Cellcom Israel, Ltd. (NYSE:CEL) has received a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One research analyst has …
BNS20d
Average
CEL-SCI Corporation (NYSE MKT: CVM) announced today that it intends to offer and sell, subject to market and other conditions shares of its common stock and warrants to purchase common stock. The securities are to …
VIENNA, Va.--(Business Wire)--CEL-SCI Corporation (NYSE MKT:CVM) announced today that it has priced its public offering of common stock and warrants. CEL-SCI announced that it has agreed to sell 34,024,000 …
In trials evaluating Axi-Cel in B-cell cancers, including diffuse large B-cell ... this could be a high-risk, high-reward stock that makes sense for long-term growth investors to buy.
Dow Jones Industrial Average